Scientific article

Quinolones and osteomyelitis: state-of-the-art

Published inDrugs, vol. 49 Suppl 2, p. 100-111
Publication date1995

The present review provides a critical quantitative analysis of the use of quinolones in osteomyelitis. Only papers published in peer-reviewed journals and related to the following areas were selected: experimental osteomyelitis, penetration of quinolones into human bone and clinical use in comparative and non-comparative studies. Cumulated results show clinical success rates of more than 90% in osteomyelitis caused by Enterobacteriaceae, after prolonged oral use of ciprofloxacin. However, further comparative studies using oral quinolones as single agents or in combination (versus standard parenteral therapy) are required in osteomyelitis due to S. aureus or P. aeruginosa, or in more complicated situations such as diabetic osteomyelitis or foreign body infection.

  • Animals
  • Anti-Infective Agents/pharmacokinetics/ therapeutic use
  • Bone and Bones/metabolism
  • Humans
  • Osteomyelitis/ drug therapy/metabolism
Citation (ISO format)
LEW, Daniel Pablo, WALDVOGEL, Francis. Quinolones and osteomyelitis: state-of-the-art. In: Drugs, 1995, vol. 49 Suppl 2, p. 100–111. doi: 10.2165/00003495-199500492-00016
ISSN of the journal0012-6667

Technical informations

Creation07/12/2010 2:37:04 PM
First validation07/12/2010 2:37:04 PM
Update time03/14/2023 3:54:32 PM
Status update03/14/2023 3:54:32 PM
Last indexation01/15/2024 8:51:56 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack